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Aneurysm enlargement after endovascular repair has been
considered a failure since the therapy was developed over a decade
ago. This was a natural assumption extending from knowledge that
sac size predicts fatal rupture risk in unrepaired aneurysms. This
assumption formed the basis for treatment of patients after endo-
vascular repair—conversion for patients with sac enlargement,
even though this can be a hazardous procedure.1 There is general
agreement that patients who continue to have enlargement with
endoleak, particularly type I endoleaks, are at risk of fatal rupture,
although perhaps at less risk than if they were untreated. Nearly all
patients with rupture after endovascular repair have had endoleak
at the time of rupture.2,3 However, there has been less consensus
about the treatment of patients with enlargement without identi-
fied endoleak—endotension. Many regard endotension as evi-
dence of endoleak even if it is not identified on imaging studies.
There was also concern for neck instability as sacs enlarge. These
underlying assumptions and past management with open conver-
sion for all enlarging aneurysms are being challenged.
The mechanisms of endotension could include graft material
defects or an inadequate seal zone that results in sac thrombus in
direct contact with the aortic flow channel, undiagnosed endoleak,
and ultrafiltration. Recently, transgraft ultrafiltration leading to
nonhemorrhagic rupture has been described after open repair.4
Other groups have described treatment of endotension with lapa-
roscopic and open sac fenestration, and they have confirmed that
iatrogenic rupture of the sac does not lead to massive hemor-
rhage.5,6 There are scattered case reports of coaxial relining as
another alternative treatment for endotension, but it remains
unknown whether this will durably reduce aneurysm sac size or be
clinically safer than open conversion or observation.
In this issue of the Journal, Mennander et al7 add to the
literature on endotension with their report of a key observation—
radiographic evidence and direct observation of spontaneous non-
hemorrhagic rupture. This occurred in multiple patients after
endovascular repair with three different devices, including polyes-
ter and polytetrafluoroethylene grafts. In two cases, the aneurysmshrinkage. The authors also note “no correlation between increas-
ing sac diameter and decreasing proximal aortic neck length or
distal iliac fixation.” On the basis of these findings, they propose
that a nonoperative approach is indicated for patients with endo-
tension. Taken together with the observations of others, their
argument is persuasive.
The authors emphasize the importance, before embarking on
observation, of assessing the seal zone and excluding endoleak “by
multiple techniques.” This requires thorough knowledge of the
failure modes, imaging options, and specific nuances of sac en-
largement associated with a particular device. As further experience
is gained, treatment of patients with endotension can be based not
on assumptions, but on the outcomes after conversion, relining,
and observation.
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